Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1994-6-16
|
pubmed:abstractText |
One hundred and eighty-seven diabetic and 105 control subjects collected timed overnight urine samples to measure the inter-individual variation in creatinine excretion rate and its determinants, and to test the relationship between albumin excretion rate (AER) and two 'surrogate measures', the albumin concentration and albumin:creatinine ratio. Creatinine excretion was 55% higher in men than women (geometric mean 8.9 mumol min-1 (95% confidence limits 4.7-17.0) compared with 5.7 (3.0-10.9); p < 0.001). Gender accounted for 31% of the variation in creatinine excretion and body mass index 1.4%; neither age nor the diabetic state had a significant effect. The relationships between AER and the two surrogate measures differed between diabetic subjects and controls such that relationships constructed from non-diabetic data would not hold true for diabetes. Likewise, the relationship between AER and albumin:creatinine ratio differed between men and women such that a ratio of 4.0 mg mmol-1 corresponded to a predicted AER of 35 micrograms min-1 in men and 23 micrograms min-1 in women. The albumin:creatinine ratio outperformed albumin concentration in terms of sensitivity and specificity and its performance was better in women than men. We conclude that the albumin:creatinine ratio is a better surrogate for AER than albumin concentration. If 'action levels' are to be defined for screening programmes, they should be derived from diabetic and not non-diabetic data and should be different in men and women. We propose a direct rather than screening role for the albumin:creatinine ratio in the management of diabetic nephropathy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0742-3071
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
32-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8181249-Adult,
pubmed-meshheading:8181249-Aged,
pubmed-meshheading:8181249-Albuminuria,
pubmed-meshheading:8181249-Biological Markers,
pubmed-meshheading:8181249-Creatinine,
pubmed-meshheading:8181249-Diabetes Mellitus,
pubmed-meshheading:8181249-Diabetes Mellitus, Type 1,
pubmed-meshheading:8181249-Diabetes Mellitus, Type 2,
pubmed-meshheading:8181249-Female,
pubmed-meshheading:8181249-Humans,
pubmed-meshheading:8181249-Male,
pubmed-meshheading:8181249-Middle Aged,
pubmed-meshheading:8181249-Reference Values,
pubmed-meshheading:8181249-Sex Characteristics,
pubmed-meshheading:8181249-Sex Factors
|
pubmed:articleTitle |
Gender and the clinical usefulness of the albumin: creatinine ratio.
|
pubmed:affiliation |
Department of Endocrinology, Hope Hospital, Salford, Manchester, UK.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|